C. Quero-Blanco

Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer

G. De Velasco, E. Alba, E. Pérez-Ruiz, 2010, Oncology.

A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma

A. Salar, M. Provencio, J. Labrador, 2015, Acta oncologica.

Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria

J. García-Alegría, P. Sánchez‐Rovira, L. Díaz-Beltrán, 2021, Medicine.